USPTO serial 77823022
TRANSGENE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TRANSGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Illkirch-graffenstaden, FR
Illkirch-graffenstaden, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bassam N. Ibrahim
BASSAM N. IBRAHIM BUCHANAN INGERSOLL & ROONEY PCPO BOX 1404ALEXANDRIA, VA 22313-1404UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in research in the field of chemistry bacteriology, virology, immunology, molecular biology, genetic engineering, gene therapy and human and veterinary medicine, namely, chemical reagents, lytic reagents, bacteriostatic reagents, fungicidal reagents, enzyme reagents, rinsing reagents and cleaning reagents all for use with hematology, cytological, particulate, virological and chemical analytical automated and semiautomated study and analysis instruments, machines and systems used in diagnostic, industrial, biological, and cytology laboratories all for scientific or research use; monoclonal antibodies and antigens for diagnostic, scientific, or research use; reagents, diluents and buffers as packaged in ready-to-use dispensing packages for scientific or research use; cell markers used as reagents for diagnostic, scientific, or research use; dyes and stains for microscopic specimen slides and flow cytometry used in diagnostic or scientific research; microspheres, fluoroscopes and monodispersed particles for use as standards, calibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biological, industrial, and academic fields for scientific or research use; whole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnostic, scientific or research use; diluents, standards, stabilizers, buffers, reference control compositions, immersion oil, sheath fluids and wetting fluids for scientific and research use; diagnostic laboratory reagents for hemoglobin testing for scientific and research use; reagents for hemoglobin testing for scientific and research use; reagents for use with automatic chemical analysis instruments in biological, chemical, industrial and clinical laboratories for scientific or research use; and cell markers for diagnostic and research use | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in treatment of cancer, central nervous system diseases, multiple sclerosis, autoimmune diseases and hypersensitivities, infectious diseases and hematological conditions | ACTIVE | — |
| 042 | Research and scientific studies in the fields of chemistry, bacteriology, genetics, human and veterinary medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Transgene, S.A.
- Other trademarks owned by Transgene, S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TRANSGENE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2013 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 3, 2013 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 30, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 29, 2012 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Oct 24, 2012 | EXT5 | SOU EXTENSION 5 FILED | — |
| Oct 24, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 26, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 25, 2012 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Apr 24, 2012 | EXT4 | SOU EXTENSION 4 FILED | — |
| Apr 24, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 27, 2011 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Oct 24, 2011 | EXT3 | SOU EXTENSION 3 FILED | — |
| Oct 24, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 21, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 20, 2011 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 20, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 15, 2011 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 15, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 16, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 14, 2010 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 14, 2010 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 14, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 4, 2010 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 9, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 4, 2010 | ALIE | ASSIGNED TO LIE | — |
| Dec 14, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 14, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 12, 2009 | NWAP | NEW APPLICATION ENTERED | — |